Neuregulin-1 prevents death from a normally lethal respiratory viral infection
PLOS Pathogens · 2025
DOI: 10.1371/journal.ppat.1013124 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Syed-Rehan A Hussain und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Nationwide Children's Hospital - The Ohio State University College of Medicine, Columbus, Ohio, United States of …. Hauptthemen laut MEDLINE: Neuregulin-1, Respirovirus Infections, Respiratory Tract Infections, Orthomyxoviridae Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Respiratory infections with RNA viruses such as respiratory syncytial virus (RSV) and influenza lead to significant morbidity and mortality. Using a natural rodent pathogen, Sendai virus (SeV), which is similar to RSV, mice made atopic with house dust mite survived a normally lethal SeV infection. One protein that we found markedly elevated in the lungs and bronchoalveolar lavage fluid of atopic mice was neuregulin-1 (NRG1). Administration of NRG1 protected naïve (non-atopic) mice from death with both SeV and mouse adapted influenza A virus (IAV). Survival was associated with reduced alveolar epithelium permeability and reduced phosphorylation of mixed lineage kinase domain-like (MLKL) protein indicating inhibition of necroptosis. In vitro , treatment of mouse lung epithelial cells with NRG1 inhibited SeV induced necroptosis, and NRG1 administration to differentiated human bronchial epithelial cells infected with RSV reduced transepithelial fluid leak and expression of necroptosis associated genes RIPK3 and MLKL , while regulating genes associated with homeostatic maintenance, suggesting stabilized epithelial integrity. In conclusion, our data demonstrate a unique function of NRG1 in respiratory viral infections by reducing alveolar leak, inhibiting epithelial necroptosis, and promoting homeostatic regulation of airway epithelium, all of which associate with markedly reduced mortality to the respiratory viral insult.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Nationwide Children's Hospital - The Ohio State University College of Medicine, Columbus, Ohio, United States of America.
- Center for Clinical and Translational Research, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
- Center for Vaccines and Immunity, Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States of America.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, United States of America.
ORCID-Profile: Syed-Rehan A Hussain, Mitchell H Grayson
Förderung
- NIAID NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- NIH
- Robert F Wolfe & Edgar T Wolfe Foundation
- The Abigail Wexner Research Institute at Nationwide Children’s Hospital
Zitieren
APA
Hussain, S. A., Rohlfing, M., Santoro, J., Chen, P., Muralidharan, K., Bochter, M. S., Peeples, M. E., & Grayson, M. H. (2025). Neuregulin-1 prevents death from a normally lethal respiratory viral infection. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013124
Vancouver
Hussain SA, Rohlfing M, Santoro J, Chen P, Muralidharan K, Bochter MS, et al. Neuregulin-1 prevents death from a normally lethal respiratory viral infection. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013124
BibTeX
@article{Hussain2025,
author = {Hussain, Syed-Rehan A and Rohlfing, Michelle and Santoro, Jennifer and Chen, Phylip and Muralidharan, Kaushik and Bochter, Matthew S and Peeples, Mark E and Grayson, Mitchell H},
title = {Neuregulin-1 prevents death from a normally lethal respiratory viral infection},
journal = {PLOS Pathogens},
year = {2025},
doi = {10.1371/journal.ppat.1013124}
}
EUVIMED